Simplex Trading, LLC Genocea Biosciences, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.01 - $1.38 $84 - $11,696	-8,476 Reduced 94.43%	500 $0
Q1 2022 May 02, 2022	SELL	$0.96 - $1.35 $21,157 - $29,752	-22,039 Reduced 71.06%	8,976 $11,000
Q4 2021 Feb 23, 2022	BUY	$0.95 - $1.99 $29,464 - $61,719	31,015 New	31,015 $35,000
Q1 2021 Apr 26, 2021	SELL	$2.35 - $4.01 $36,006 - $61,441	-15,322 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.91 - $2.67 $29,265 - $40,909	15,322 New	15,322 $37,000
Q3 2020 Oct 14, 2020	SELL	$1.81 - $5.53 $427 - $1,305	-236 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$1.66 - $3.06 $391 - $722	236 New	236 $0
Q1 2020 Apr 29, 2020	SELL	$1.26 - $2.73 $151 - $327	-120 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$2.05 - $2.82 $3,942 - $5,422	-1,923 Reduced 94.13%	120 $0
Q3 2019 Oct 15, 2019	BUY	$2.9 - $4.07 $5,924 - $8,315	2,043 New	2,043 $5,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.